Therapeutische Nanobodies gegen SARS-CoV-2
Crossref DOI link: https://doi.org/10.1007/s12268-022-1684-y
Published Online: 2022-02-13
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Güttler, Thomas
Dobbelstein, Matthias
Görlich, Dirk
Text and Data Mining valid from 2022-02-01
Version of Record valid from 2022-02-13
Article History
First Online: 13 February 2022